A Single Dose of the DENV-1 Candidate Vaccine rDEN1Δ30 Is Strongly Immunogenic and Induces Resistance to a Second Dose in a Randomized Trial

Dengue is an emerging infectious disease that has become the most important arboviral infection worldwide. There are four serotypes of dengue virus, DENV-1, DENV-2, DENV-3, and DENV-4, each capable of causing the full spectrum of disease. rDEN1Δ30 is a live attenuated investigational vaccine for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Durbin, Anna P., Whitehead, Stephen S., Shaffer, Donna, Elwood, Dan, Wanionek, Kimberli, Thumar, Bhavin, Blaney, Joseph E., Murphy, Brian R., Schmidt, Alexander C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149013/
https://www.ncbi.nlm.nih.gov/pubmed/21829748
http://dx.doi.org/10.1371/journal.pntd.0001267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149013/
https://www.ncbi.nlm.nih.gov/pubmed/21829748
http://dx.doi.org/10.1371/journal.pntd.0001267

Ejemplares similares